NorstellaLinQ: Better Together: Getting the Full Patient Picture

This page is a product/feature overview rather than a results-based case study. It describes NorstellaLinQ integrating "clinically rich, domain-specific data with real-world data and proprietary assets from across all Norstella brands" into a unified patient/market-insight platform, applying AI/ML for predictive and prescriptive guidance on decisions like molecule investment, trial-investigator recruitment, and sales-force optimization. No specific quantitative outcomes or named client results are given on the page.

The customer is anonymised in Norstella’s own case study — not withheld by us.

Norstella is a holding company merging several pharma-intelligence brands — Citeline (trial intelligence), Evaluate (forecasting), MMIT (payer/formulary data) and Panalgo (real-world analytics) — into one data asset.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.